Journal of Clinical Oncology, Vol 18, Issue 2
(January), 2000: 307
© 2000 American Society for Clinical Oncology
Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy
By Omer N. Koç,
Stanton L. Gerson,
Brenda W. Cooper,
Stephanie M. Dyhouse,
Stephen E. Haynesworth,
Arnold I. Caplan,
Hillard M. Lazarus
From the Departments of Medicine and Biology, Case Western Reserve University; and Division of Hematology/Oncology and Ireland Cancer Center of University Hospitals of Cleveland, Cleveland, OH.
Address reprint requests to Omer N. Koç, MD, Case Western Reserve University, BRB-3 Hematology/Oncology, 10900 Euclid Ave, Cleveland OH 44106; email onk2{at}po.cwru.edu
PURPOSE: Multipotential mesenchymal stem cells (MSCs) are found in human bone marrow and are shown to secrete hematopoietic cytokines and support hematopoietic progenitors in vitro. We hypothesized that infusion of autologous MSCs after myeloablative therapy would facilitate engraftment by hematopoietic stem cells, and we investigated the feasibility, safety, and hematopoietic effects of culture-expanded MSCs in breast cancer patients receiving autologous peripheral-blood progenitor-cell (PBPC) infusion.
PATIENTS AND METHODS: We developed an efficient method of isolating and culture-expanding a homogenous population of MSCs from a small marrow-aspirate sample obtained from 32 breast cancer patients. Twenty-eight patients were given high-dose chemotherapy and autologous PBPCs plus culture-expanded MSC infusion and daily granulocyte colony-stimulating factor.
RESULTS: Human MSCs were successfully isolated from a mean ± SD of 23.4 ± 5.9 mL of bone marrow aspirate from all patients. Expansion cultures generated greater than 1 x 106 MSCs/kg for all patients over 20 to 50 days with a mean potential of 5.6 to 36.3 x 106 MSCs/kg after two to six passages, respectively. Twenty-eight patients were infused with 1 to 2.2 x 106 expanded autologous MSCs/kg intravenously over 15 minutes. There were no toxicities related to the infusion of MSCs. Clonogenic MSCs were detected in venous blood up to 1 hour after infusion in 13 of 21 patients (62%). Median time to achieve a neutrophil count greater than 500/µL and platelet count  20,000/µL untransfused was 8 days (range, 6 to 11 days) and 8.5 days (range, 4 to 19 days), respectively.
CONCLUSION: This report is the first describing infusion of autologous MSCs with therapeutic intent. We found that autologous MSC infusion at the time of PBPC transplantation is feasible and safe. The observed rapid hematopoietic recovery suggests that MSC infusion after myeloablative therapy may have a positive impact on hematopoiesis and should be tested in randomized trials.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Tommila, A. Jokilammi, P. Terho, T. Wilson, R. Penttinen, and E. Ekholm
Hydroxyapatite coating of cellulose sponges attracts bone-marrow-derived stem cells in rat subcutaneous tissue
J R Soc Interface,
October 6, 2009;
6(39):
873 - 880.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kumamoto, T. Nishiwaki, N. Matsuo, H. Kimura, and K. Matsushima
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Eur. Respir. J.,
September 1, 2009;
34(3):
740 - 748.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Spaggiari, H. Abdelrazik, F. Becchetti, and L. Moretta
MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2
Blood,
June 25, 2009;
113(26):
6576 - 6583.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Li, S. Chen, J. Yuan, Y. Yang, J. Li, J. Ma, X. Wu, M. Freund, K. Pollok, H. Hanenberg, et al.
Mesenchymal stem/progenitor cells promote the reconstitution of exogenous hematopoietic stem cells in Fancg-/- mice in vivo
Blood,
March 5, 2009;
113(10):
2342 - 2351.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Wang, J. E. Dennis, A. Awadallah, L. A. Solchaga, J. Molter, Y. Kuang, N. Salem, Y. Lin, H. Tian, J. A. Kolthammer, et al.
Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging
Physiol Genomics,
March 3, 2009;
37(1):
23 - 34.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Lee, J. E. Dennis, and S. L. Gerson
Imaging Stem Cell Implant for Cellular-Based Therapies
Experimental Biology and Medicine,
August 1, 2008;
233(8):
930 - 940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Moon, J. R. Lee, B. C. Jee, C. S. Suh, S. H. Kim, H. J. Lim, and H. K. Kim
Successful vitrification of human amnion-derived mesenchymal stem cells
Hum. Reprod.,
August 1, 2008;
23(8):
1760 - 1770.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. K. Rebelatto, A. M. Aguiar, M. P. Moretao, A. C. Senegaglia, P. Hansen, F. Barchiki, J. Oliveira, J. Martins, C. Kuligovski, F. Mansur, et al.
Dissimilar Differentiation of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, and Adipose Tissue
Experimental Biology and Medicine,
July 1, 2008;
233(7):
901 - 913.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Eliopoulos, M. Francois, M.-N. Boivin, D. Martineau, and J. Galipeau
Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer Therapy
Cancer Res.,
June 15, 2008;
68(12):
4810 - 4818.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Sessarego, A. Parodi, M. Podesta, F. Benvenuto, M. Mogni, V. Raviolo, M. Lituania, A. Kunkl, G. Ferlazzo, F. D. Bricarelli, et al.
Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application
Haematologica,
March 1, 2008;
93(3):
339 - 346.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sasaki, R. Abe, Y. Fujita, S. Ando, D. Inokuma, and H. Shimizu
Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type
J. Immunol.,
February 15, 2008;
180(4):
2581 - 2587.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-Y. Wang, Y. Lan, W.-Y. He, L. Zhang, H.-Y. Yao, C.-M. Hou, Y. Tong, Y.-L. Liu, G. Yang, X.-D. Liu, et al.
Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos
Blood,
February 15, 2008;
111(4):
2436 - 2443.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Jones and D. McGonagle
Human bone marrow mesenchymal stem cells in vivo
Rheumatology,
February 1, 2008;
47(2):
126 - 131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M. C. Mingari, and L. Moretta
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
Blood,
February 1, 2008;
111(3):
1327 - 1333.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Meuleman, G. Vanhaelen, T. Tondreau, P. Lewalle, J. Kwan, J. Bennani, P. Martiat, L. Lagneaux, and D. Bron
Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report
Haematologica,
January 1, 2008;
93(1):
e11 - e13.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Love, F. Wang, J. Dennis, A. Awadallah, N. Salem, Y. Lin, A. Weisenberger, S. Majewski, S. Gerson, and Z. Lee
Imaging of Mesenchymal Stem Cell Transplant by Bioluminescence and PET
J. Nucl. Med.,
December 1, 2007;
48(12):
2011 - 2020.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Nauta and W. E. Fibbe
Immunomodulatory properties of mesenchymal stromal cells
Blood,
November 15, 2007;
110(10):
3499 - 3506.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Bernardo, N. Zaffaroni, F. Novara, A. M. Cometa, M. A. Avanzini, A. Moretta, D. Montagna, R. Maccario, R. Villa, M. G. Daidone, et al.
Human Bone Marrow Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term In vitro Culture and Do Not Exhibit Telomere Maintenance Mechanisms
Cancer Res.,
October 1, 2007;
67(19):
9142 - 9149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Zhang, N. Mal, M. Kiedrowski, M. Chacko, A. T. Askari, Z. B. Popovic, O. N. Koc, and M. S. Penn
SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction
FASEB J,
October 1, 2007;
21(12):
3197 - 3207.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Batten, N. A Rosenthal, and M. H Yacoub
Immune response to stem cells and strategies to induce tolerance
Phil Trans R Soc B,
August 29, 2007;
362(1484):
1343 - 1356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Cahill, D. Wenkert, S. A. Perlman, A. Steele, S. P. Coburn, W. H. McAlister, S. Mumm, and M. P. Whyte
Infantile Hypophosphatasia: Transplantation Therapy Trial Using Bone Fragments and Cultured Osteoblasts
J. Clin. Endocrinol. Metab.,
August 1, 2007;
92(8):
2923 - 2930.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Locatelli, R. Maccario, and F. Frassoni
Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?
Haematologica,
July 1, 2007;
92(7):
872 - 877.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Shi, J. Li, L. Liao, B. Chen, B. Li, L. Chen, H. Jia, and R. C. Zhao
Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice
Haematologica,
July 1, 2007;
92(7):
897 - 904.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Ries, V. Egea, M. Karow, H. Kolb, M. Jochum, and P. Neth
MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines
Blood,
May 1, 2007;
109(9):
4055 - 4063.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. De Becker, P. Van Hummelen, M. Bakkus, I. Vande Broek, J. De Wever, M. De Waele, and I. Van Riet
Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3
Haematologica,
April 1, 2007;
92(4):
440 - 449.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. J. Gang, D. Bosnakovski, C. A. Figueiredo, J. W. Visser, and R. C. R. Perlingeiro
SSEA-4 identifies mesenchymal stem cells from bone marrow
Blood,
February 15, 2007;
109(4):
1743 - 1751.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Sun, H. Zhang, X. Feng, Y. Hou, L. Lu, and L. Fan
Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus
Lupus,
February 1, 2007;
16(2):
121 - 128.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Drouet, J.-F. Mayol, F. Norol, A. Peinnequin, J.-P. Zarski, C. Letoublon, and F. Herodin
Lack of evidence of sustained hematopoietic reconstitution after transplantation of unmanipulated adult liver stem cells in monkeys
Haematologica,
February 1, 2007;
92(2):
248 - 251.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Sato, K. Ozaki, I. Oh, A. Meguro, K. Hatanaka, T. Nagai, K. Muroi, and K. Ozawa
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Blood,
January 1, 2007;
109(1):
228 - 234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Ruster, S. Gottig, R. J. Ludwig, R. Bistrian, S. Muller, E. Seifried, J. Gille, and R. Henschler
Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells
Blood,
December 1, 2006;
108(12):
3938 - 3944.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. van Laar and A. Tyndall
Adult stem cells in the treatment of autoimmune diseases
Rheumatology,
October 1, 2006;
45(10):
1187 - 1193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Nauta, G. Westerhuis, A. B. Kruisselbrink, E. G. A. Lurvink, R. Willemze, and W. E. Fibbe
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Blood,
September 15, 2006;
108(6):
2114 - 2120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Sudres, F. Norol, A. Trenado, S. Gregoire, F. Charlotte, B. Levacher, J.-J. Lataillade, P. Bourin, X. Holy, J.-P. Vernant, et al.
Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice.
J. Immunol.,
June 15, 2006;
176(12):
7761 - 7767.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Stagg, S. Pommey, N. Eliopoulos, and J. Galipeau
Interferon-{gamma}-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell
Blood,
March 15, 2006;
107(6):
2570 - 2577.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Muguruma, T. Yahata, H. Miyatake, T. Sato, T. Uno, J. Itoh, S. Kato, M. Ito, T. Hotta, and K. Ando
Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment
Blood,
March 1, 2006;
107(5):
1878 - 1887.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
Blood,
February 15, 2006;
107(4):
1484 - 1490.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Minguell and A. Erices
Mesenchymal Stem Cells and the Treatment of Cardiac Disease
Experimental Biology and Medicine,
January 1, 2006;
231(1):
39 - 49.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Eliopoulos, J. Stagg, L. Lejeune, S. Pommey, and J. Galipeau
Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice
Blood,
December 15, 2005;
106(13):
4057 - 4065.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Leri, J. Kajstura, and P. Anversa
Cardiac Stem Cells and Mechanisms of Myocardial Regeneration
Physiol Rev,
October 1, 2005;
85(4):
1373 - 1416.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Krampera, A. Pasini, A. Rigo, M. T. Scupoli, C. Tecchio, G. Malpeli, A. Scarpa, F. Dazzi, G. Pizzolo, and F. Vinante
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation
Blood,
July 1, 2005;
106(1):
59 - 66.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Podesta, F. Benvenuto, A. Pitto, O. Figari, A. Bacigalupo, S. Bruzzone, L. Guida, L. Franco, L. Paleari, N. Bodrato, et al.
Concentrative Uptake of Cyclic ADP-ribose Generated by BST-1+ Stroma Stimulates Proliferation of Human Hematopoietic Progenitors
J. Biol. Chem.,
February 18, 2005;
280(7):
5343 - 5349.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Aggarwal and M. F. Pittenger
Human mesenchymal stem cells modulate allogeneic immune cell responses
Blood,
February 15, 2005;
105(4):
1815 - 1822.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D Thierry, J M Bertho, A Chapel, and P Gourmelon
Cell therapy for the treatment of accidental radiation overexposure
Br. J. Radiol.,
January 1, 2005;
Supplement_27(1):
175 - 179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. F. Wynn, C. A. Hart, C. Corradi-Perini, L. O'Neill, C. A. Evans, J. E. Wraith, L. J. Fairbairn, and I. Bellantuono
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow
Blood,
November 1, 2004;
104(9):
2643 - 2645.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H T Hassan and M El-Sheemy
Adult bone-marrow stem cells and their potential in medicine
J R Soc Med,
October 1, 2004;
97(10):
465 - 471.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bensidhoum, A. Chapel, S. Francois, C. Demarquay, C. Mazurier, L. Fouillard, S. Bouchet, J. M. Bertho, P. Gourmelon, J. Aigueperse, et al.
Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment
Blood,
May 1, 2004;
103(9):
3313 - 3319.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Devine, C. Cobbs, M. Jennings, A. Bartholomew, and R. Hoffman
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates
Blood,
April 15, 2003;
101(8):
2999 - 3001.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Horwitz, P. L. Gordon, W. K. K. Koo, J. C. Marx, M. D. Neel, R. Y. McNall, L. Muul, and T. Hofmann
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
PNAS,
June 25, 2002;
99(13):
8932 - 8937.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Campagnoli, I. A. G. Roberts, S. Kumar, P. R. Bennett, I. Bellantuono, and N. M. Fisk
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
Blood,
October 15, 2001;
98(8):
2396 - 2402.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Minguell, A. Erices, and P. Conget
Mesenchymal Stem Cells
Experimental Biology and Medicine,
June 1, 2001;
226(6):
507 - 520.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Cilloni, C. Carlo-Stella, F. Falzetti, G. Sammarelli, E. Regazzi, S. Colla, V. Rizzoli, F. Aversa, M. F. Martelli, and A. Tabilio
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation
Blood,
November 15, 2000;
96(10):
3637 - 3643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
